BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21871197)

  • 1. How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries.
    Kemp A; Preen DB; Glover J; Semmens J; Roughead EE
    Aust Health Rev; 2011 Aug; 35(3):341-9. PubMed ID: 21871197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical expenditure compared across countries.
    van Mosseveld C
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Aust N Z J Public Health; 2009 Jun; 33(3):246-52. PubMed ID: 19630844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage for mental health treatment: do the gaps still persist?
    Zuvekas SH; Meyerhoefer CD
    J Ment Health Policy Econ; 2006 Sep; 9(3):155-63. PubMed ID: 17031020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription drug accessibility and affordability in the United States and abroad.
    Morgan S; Kennedy J
    Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health care and out-of-pocket expenditures in Europe: results from the ESEMeD project.
    Sevilla-Dedieu C; Kovess-Masfety V; Gilbert F; Vilagut G; Koenig HH; Bruffaerts R; Haro JM; Alonso J
    J Ment Health Policy Econ; 2011 Jun; 14(2):95-105. PubMed ID: 21881165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of universal health insurance: lessons from South Korea.
    Moon S; Shin J
    Healthc Q; 2007; 10(3):116-30. PubMed ID: 17626554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-care expenditure and health policy in the USA versus other high-spending OECD countries.
    Lorenzoni L; Belloni A; Sassi F
    Lancet; 2014 Jul; 384(9937):83-92. PubMed ID: 24993914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear Granger Causality between Health Care Expenditure and Economic Growth in the OECD and Major Developing Countries.
    Ye L; Zhang X
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30205463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Government health expenditure, out-of-pocket payment and social inequality: A cross-national analysis of China and OECD countries.
    Zhang D; Rahman KMA
    Int J Health Plann Manage; 2020 Sep; 35(5):1111-1126. PubMed ID: 32725673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of self-reported medicine underuse due to cost: a comparison of seven countries.
    Kemp A; Roughead E; Preen D; Glover J; Semmens J
    J Health Serv Res Policy; 2010 Apr; 15(2):106-14. PubMed ID: 20203082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
    Sarnak DO; Squires D; Kuzmak G; Bishop S
    Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care expenditures and ageing: an international comparison.
    Seshamani M; Gray A
    Appl Health Econ Health Policy; 2003; 2(1):9-16. PubMed ID: 14619269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drug spending trends for the privately insured in Maryland, 2000-2001.
    Shaya FT; Blume S; Mullins CD
    Health Aff (Millwood); 2004; 23(5):226-32. PubMed ID: 15371389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of changes in private health expenditure on New Zealand households.
    Hopkins S; Cumming J
    Health Policy; 2001 Dec; 58(3):215-29. PubMed ID: 11641000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health spending in OECD countries: obtaining value per dollar.
    Anderson GF; Frogner BK
    Health Aff (Millwood); 2008; 27(6):1718-27. PubMed ID: 18997231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic patterns in national health expenditure.
    Musgrove P; Zeramdini R; Carrin G
    Bull World Health Organ; 2002; 80(2):134-42. PubMed ID: 11953792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.